Abstract
Normal rats were given a daily dose of gliclazide (8 mg/kg) for a period of 6 days. Twenty-four hours after the treatment period, the treated animals had a significant increase in the initial rate of glucose utlilization during intravenous glucose tolerance tests when compared to the controls. Insulin-stimulated 3-0-Methylglucose transport and glucose oxidation were potentiated in adipocytes prepared from gliclazide-treated rats, indicating that improved glycemic control can, at least partly, be attributed to extrapancreatic effects. The drug treatment did not induce any changes in total insulin binding, implicating that the extrapancreatic effects of this hypoglycemic drug are mediated through a post-binding site.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
